Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 86 (9), 1036-1040
- https://doi.org/10.1016/s0002-9149(00)01147-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interaction of Myocytes and Nonmyocytes Is Necessary for Mechanical Stretch to Induce ANP/BNP Production in Cardiocyte CultureJournal of Cardiovascular Pharmacology, 1998
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993
- Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.Circulation, 1991
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.JCI Insight, 1991
- Sympathoinhibitory effects of atrial natriuretic factor in normal humans.Circulation, 1990
- Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.JCI Insight, 1989
- Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.Circulation, 1987
- Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the HumanScience, 1986
- Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte HomeostasisNew England Journal of Medicine, 1985